Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Kaplan-Meier survival analysis
Overall survival (OS): Median 57.5 months (range 11-120). | Download Scientific Diagram
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
MOS - "Median overall survival time" by AcronymsAndSlang.com
Extrapolation from Progression Free Survival to Overall Survival in Oncology
Kaplan-Meier survival analysis
Disease Free Survival - an overview | ScienceDirect Topics
Tutorial about Hazard Ratios - Students 4 Best Evidence
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Progression Free Survival - an overview | ScienceDirect Topics
Measures of Cancer Survival
Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching | PLOS ONE
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
